Tower Research Capital LLC (TRC) - FIRST WAVE BIOPHARMA INC COM ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of FIRST WAVE BIOPHARMA INC COM
ValueSharesWeighting
Q3 2023$3,239
-73.6%
11,169
+45.9%
0.00%
Q2 2023$12,246
+101950.0%
7,654
+71.0%
0.00%
Q1 2023$124,4770.00%
Other shareholders
FIRST WAVE BIOPHARMA INC COM shareholders Q4 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 89,856$240,8140.00%
Kathleen S. Wright Associates Inc. 22$590.00%
UBS Group AG 4,106$11,0040.00%
US BANCORP \DE\ 24$640.00%
BANK OF AMERICA CORP /DE/ 1$30.00%
FIRST MANHATTAN CO. LLC. 1$20.00%
WELLS FARGO & COMPANY/MN 33$890.00%
STATE STREET CORP 11,797$31,6160.00%
ACADIAN ASSET MANAGEMENT LLC 13,258$350.00%
BlackRock Inc. 397$1,0640.00%
View complete list of FIRST WAVE BIOPHARMA INC COM shareholders